Clinical Trials on Healthy Men in Hong Kong

Total 175 results

Hoffmann-La Roche

Completed

A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.

Healthy Participants

Hong Kong
Chinese University of Hong Kong

Unknown

Shinrin-Yoku (Forest Bathing) on Psychological Well-being

Mental Health Wellness

Hong Kong
Mind Mental Health Hong Kong Limited
Chinese University of Hong Kong

Recruiting

Evaluation of Training Curriculum and Service of Improving Access to Community Therapies (iACT)

Depression | Stress | Anxiety | Distress, Emotional | Mental Health Issue

China
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Recruiting

The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families

Mental Health Wellness 1

Hong Kong
The Hong Kong Polytechnic University

Recruiting

Development and Evaluation of an Online Multidimensional Musculoskeletal Health Programme

Occupational Health

Hong Kong
Chinese University of Hong Kong

Completed

All-encompassing Program Led by Diabetes Specialist Team (EMERALD)

Health Care Delivery

China
The University of Hong Kong
The Hong Kong Jockey Club Charities Trust

Completed

Enhancing Family Well-being Project

Family Relationship, Family Health, Happiness and Harmony

China
Chinese University of Hong Kong

Recruiting

Archival of Human Biological Samples in CU-Med Biobank

Heart Diseases | Kidney Diseases | Healthy | Diabetes | Cancer | Neurological Diseases or Conditions | Other Disease

Hong Kong
Chinese University of Hong Kong

Recruiting

Promoting HIV Self-testing Among MSM During COVID-19 Pandemic

Health Behavior

Hong Kong
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers.

Healthy Participants

Hong Kong
Chinese University of Hong Kong

Not yet recruiting

Randomized Controlled Trial on Precision Mental Health

Mental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental Health

Hong Kong
Chinese University of Hong Kong

Completed

Zentangle on Psychological Well-being

Mental Health Wellness

Hong Kong
Biogen

Completed

Phase 1 Study to Evaluate the PK, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Healthy Volunteers (109HV108)

Healthy

Australia, China
The University of Hong Kong

Completed

10-year Risk Prediction Models of Complications and Mortality of DM in Hong Kong

Cardiovascular Diseases | Diabetes Mellitus | Mortality | Primary Health Care

Hong Kong, China
The Hong Kong Polytechnic University

Completed

Social Media-based Electronic Bibliotherapy for Dementia Caregivers

Quality of Life | Mental Health | Dementia Caregivers

Hong Kong
Biogen

Completed

Phase 1 Study to Evaluate the PK, Safety, Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Healthy Volunteers

Healthy Volunteers

Australia, China
Hong Kong Baptist University

Completed

Effects of a PA Intervention for Fatness and Fitness in Adolescents With Intellectual Disability

Obesity | Intellectual Disability | Health-related Physical Fitness

China
Chinese University of Hong Kong

Completed

Evaluation of Chatbot for Mental Well-being

Mental Well-being | Mental Health Literacy

Hong Kong
Chinese University of Hong Kong

Completed

Evaluation of Online Mental Well-being Intervention for Working Adults

Mental Health Wellness 1 | Mental Well-being | Mental Health Issue

Hong Kong
The Hong Kong Polytechnic University

Completed

Effects of a Video-based mHealth Program

Mobile Health | Older Adult

Hong Kong
Biogen

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy Participants

Healthy Volunteers

New Zealand, Hong Kong
Hoffmann-La Roche

Completed

A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous Administration

Healthy Volunteers

New Zealand, Taiwan, Australia, Hong Kong, Singapore
Novartis Pharmaceuticals

Terminated

Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.

Advanced Hepatocellular Carcinoma With c-MET Dysregulation

China, Hong Kong, Thailand, Singapore
Yuhan Corporation

Completed

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects With Mild Allergic Diseases

Atopic Healthy Subjects | Adult Subjects With Mild Allergic Diseases

Korea, Republic of
Symphogen A/S

Completed

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

NSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene Amplification

United States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of SHR7280 Tablets in Healthy Subjects.

Healthy Subjects

China
Jiaxing AnDiCon Biotech Co.,Ltd

Recruiting

Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose

Healthy Volunteer

China
Haisco Pharmaceutical Group Co., Ltd.

Completed

Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers

Healthy Volunteers

China
Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

Drug-drug Interaction Study of XZP-3621 Tablet

Healthy Subjects

China
Concert Pharmaceuticals

Completed

Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers

Healthy

United States
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers

Healthy

United States
Halozyme Therapeutics

Completed

A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects

Healthy

United States
Zhujiang Hospital
Zhongshan Bo Ai Hospital

Active, not recruiting

Effects of IAP-EOGBSD on Offspring's Gut Microbiome and Immunity.

Healthy | Microbiome | Metabolism

China
Chinook Therapeutics, Inc.

Completed

Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects

Healthy Volunteer

United States
Eisai Inc.

Completed

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants

Healthy Participants

United States
Celgene

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.

Healthy Volunteers

United States
Biogen

Completed

Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

Healthy Volunteers

United States
Green Cross Corporation

Completed

A Study of MG1111 in Healthy Children

Healthy Children

Korea, Republic of
Ipsen

Completed

Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants

Healthy Volunteers

United States
Yuhan Corporation

Completed

YH4808 Postprandial PK/PD Study in Healthy Subjects

Healthy

Korea, Republic of
Sage Therapeutics

Completed

A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers

Healthy Volunteers

Korea, Republic of
Omeros Corporation

Unknown

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Lupus Nephritis | IgAN | C3 Glomerulopathy | MN

United States, Hong Kong
H. Lundbeck A/S

Completed

A Study Investigating Lu AG22515 in Healthy Adults

Healthy Participants

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

Healthy

United States
Neurana Pharmaceuticals, Inc.

Completed

Effects of Tolperisone on Measures of Drowsiness and Cognitive Function

Healthy

United States
AstraZeneca

Completed

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Healthy Volunteers

United States

3

Subscribe